MIDAS Research Initiates Coverage of Arrowhead Research Corp.
MANNHEIM, Germany, January 12 /PRNewswire/ -- MIDAS Research has published a research report on the nanotechnology company Arrowhead Research Corp. (Nasdaq: ARWR / Berlin Exchange: HDP) with a 12 month target of USD 6.00 and a speculative buy recommendation. A copy of the report is available in both German and English at www.midasresearch.de . Arrowhead Research is developing products and intellectual property in a number of nanotech fields including novel drug delivery systems, semiconductor materials and tools for atomic force microscopy. As judged by the breadth and diversity of Arrowheads intellectual property the company is likely to gain much broader attention by investors concludes MIDAS Research technology analyst Karsten Siebert, CEFA, in his report. MIDAS Research is an independent stock research company with a global focus on emerging industries like nanotech and biotech. Recent reports have successfully highlighted stocks like MorphoSys (GER), pSivida (AUS), Callisto Pharma (USA) or EpiTan (AUS). For further information please contact: Michael Drepper, Info@midas-research.de, +49-621-4306130
SOURCE MIDAS Research